InvestorsHub Logo

thundersteel

08/31/22 12:09 PM

#21384 RE: glenngroove #21383

Just sent an email to vyome about phase 2 vb 1953 study-I hope

I get a response. If I do, I will share the info.

My main contention-is it has nothing to do with the drug

but that the study was set up- hospitals-study groups,
enrollment and different strengths of vb 1953-
to be used with a placebo/group. Look to me
that it never got off the found or was completed,

To me, this is not an issue with the drug, but costs
associated with the study.

But, that is why I wrote the company. I doubt I hear
anything, but if I do- you peeps will be informed.

TS